Add to balance / Manage account | User: | Log out |
Prospect News home > News index > List of issuers A > Headlines for Aradigm Corp. > News item |
Millenco reports 5.5% stake in Aradigm
By Lisa Kerner
Charlotte, N.C., Nov. 26 - Investors led by Millenco LLC bought 699,355 shares of Aradigm Corp. stock priced from $1.55 to $1.96 to each.
The shares were purchased between Nov. 1 and Nov. 20, according to a schedule 13D filing with the Securities and Exchange Commission.
Millenco owns 2,946,148 shares or some 5.5% of the Hayward, Calif., company. Aradigm develops non-invasive delivery systems for self-administration of biopharmaceuticals and small molecules.
© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere.
For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.